Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121652 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02121652: Completed NA study, sponsored by State University of New York at Buffalo.
NCT02121652 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121652, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective for insomnia in lung cancer survivors.
Primary Outcome
Sleep Efficiency \> 85% measured with a seven-day sleep diary. The score is calculated based on participants' recording of time asleep (minutes) divided by time in bed (minutes). Sleep Efficiency greater than or equal to 85% indicates good sleep quality, and values less than 85% indicate poor sleep quality.
Interventions
- BEHAVIORAL Cognitive behavioral therapy for insomnia
- BEHAVIORAL Healthy eating control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02121652 record still lists
NCT02121652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive behavioral therapy for insomnia is the first listed.
NCT02121652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02121652 about?
NCT02121652 is a clinical study titled "Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer". The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective for insomnia in lung cancer survivors.
What is the current status of trial NCT02121652?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2014-04. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02121652?
The interventions under investigation include: Cognitive behavioral therapy for insomnia (BEHAVIORAL), Healthy eating control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02121652?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02121652's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia